Update: 19.11.2024
Last week: 45 week 2024 (04.11.2024 - 10.11.2024)
Last full month: October 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 10 524 | 4.9% | 13.1% | 0.1 | 17 889 918 | 2.6% | 8.6% | 0 | 3.8% |
| MoM | 46 299 | 25.2% | 13.5% | 0.1 | 78 544 747 | 16.9% | 8.8% | -0.4 | 24.4% |
| YTD | 353 560 | 23.2% | 12.1% | 3.2 | 712 775 027 | 31.1% | 9.3% | 1.8 | -9.1% |
| MAT | 407 418 | 23.3% | 11.9% | 2.9 | 825 992 702 | 32.9% | 9.2% | 1.7 | -7.0% |
| BRAINMAX | |||||||||
| WoW | 2 859 | 3.6% | 100.0% | 0 | 9 374 206 | -2.6% | 100.0% | 0 | 3.6% |
| MoM | 11 465 | 51.5% | 100.0% | 0 | 38 983 593 | 47.0% | 100.0% | 0 | 51.5% |
| YTD | 65 207 | 72.4% | 100.0% | 0 | 227 762 439 | 76.1% | 100.0% | 0 | 72.4% |
| MAT | 74 043 | 75.7% | 100.0% | 0 | 259 390 120 | 81.2% | 100.0% | 0 | 75.7% |
| GOLDLINE PLUS | |||||||||
| WoW | 15 238 | 7.7% | 47.7% | 1.4 | 47 857 867 | 6.7% | 39.3% | 0.8 | 4.6% |
| MoM | 65 432 | 6.8% | 46.1% | 0.2 | 202 749 324 | 6.6% | 37.8% | 0.1 | 6.4% |
| YTD | 730 743 | -5.0% | 45.2% | 0.4 | 2 294 345 423 | -3.2% | 37.0% | -2.7 | -5.9% |
| MAT | 830 351 | -3.6% | 45.3% | 0.5 | 2 614 694 229 | -0.9% | 37.3% | -2.6 | -4.6% |
| MIGRENIUM | |||||||||
| WoW | 10 256 | 7.7% | 0.5% | 0 | 3 503 167 | 6.6% | 0.6% | 0 | -1.1% |
| MoM | 40 982 | -0.4% | 0.4% | 0 | 13 954 118 | 0.8% | 0.5% | 0 | 3.5% |
| YTD | 506 183 | -11.1% | 0.5% | -0.1 | 160 334 390 | 50.9% | 0.7% | 0.2 | 6.0% |
| MAT | 578 626 | -12.8% | 0.5% | -0.1 | 176 741 217 | 43.5% | 0.6% | 0.1 | 8.0% |
| MODELAX-N | |||||||||
| WoW | 28 451 | 1.8% | 20.6% | -0.1 | 14 080 012 | 2.7% | 13.8% | -0.1 | 2.0% |
| MoM | 119 788 | 11.4% | 20.1% | -0.5 | 57 090 549 | 12.1% | 13.2% | -0.3 | 13.9% |
| YTD | 1 273 933 | 26.9% | 22.1% | 3.2 | 563 940 570 | 74.9% | 14.3% | 3.8 | 8.3% |
| MAT | 1 437 849 | 29.9% | 21.4% | 3.2 | 624 362 657 | 74.8% | 13.7% | 3.5 | 10.5% |
| REDUXIN | |||||||||
| WoW | 10 110 | 3.1% | 31.6% | -0.5 | 53 365 882 | 4.9% | 43.8% | 0.1 | 4.6% |
| MoM | 46 001 | 7.6% | 32.4% | 0.4 | 237 476 007 | 7.9% | 44.3% | 0.6 | 6.4% |
| YTD | 529 268 | -7.0% | 32.8% | -0.4 | 2 807 799 859 | 11.3% | 45.3% | 3 | -5.9% |
| MAT | 597 861 | -6.1% | 32.6% | -0.5 | 3 157 734 889 | 13.2% | 45.0% | 2.9 | -4.6% |
| REDUXIN FORTE | |||||||||
| WoW | 3 074 | -1.0% | 9.6% | -0.5 | 12 644 430 | -2.4% | 10.4% | -0.7 | 4.6% |
| MoM | 13 965 | 1.4% | 9.8% | -0.5 | 59 017 541 | 0.1% | 11.0% | -0.7 | 6.4% |
| YTD | 147 282 | 1.2% | 9.1% | 0.6 | 633 339 160 | 11.9% | 10.2% | 0.7 | -5.9% |
| MAT | 167 730 | 2.8% | 9.1% | 0.7 | 721 073 641 | 14.0% | 10.3% | 0.7 | -4.6% |
| SALVISAR | |||||||||
| WoW | 16 399 | 8.7% | 2.2% | 0.2 | 7 281 600 | 9.7% | 2.0% | 0.2 | 0.8% |
| MoM | 58 452 | 22.5% | 1.7% | 0.2 | 25 561 706 | 25.4% | 1.5% | 0.2 | 8.1% |
| YTD | 475 049 | 8.5% | 1.4% | 0.1 | 197 481 927 | 37.1% | 1.3% | 0.2 | -2.8% |
| MAT | 535 468 | -0.2% | 1.4% | 0 | 217 218 555 | 21.9% | 1.2% | 0.1 | -0.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 353 560 | 23.2% | 12.1% | 3.2 | 712 775 027 | 31.1% | 9.3% | 1.8 | -9.1% |
| BRAINMAX | 65 207 | 72.4% | 100.0% | 0 | 227 762 439 | 76.1% | 100.0% | 0 | 72.4% |
| GOLDLINE PLUS | 730 743 | -5.0% | 45.2% | 0.4 | 2 294 345 423 | -3.2% | 37.0% | -2.7 | -5.9% |
| MIGRENIUM | 506 183 | -11.1% | 0.5% | -0.1 | 160 334 390 | 50.9% | 0.7% | 0.2 | 6.0% |
| MODELAX-N | 1 273 933 | 26.9% | 22.1% | 3.2 | 563 940 570 | 74.9% | 14.3% | 3.8 | 8.3% |
| REDUXIN CAPS | 529 268 | -7.0% | 32.8% | -0.4 | 2 807 799 859 | 11.3% | 45.3% | 3 | -5.9% |
| REDUXIN FORTE | 147 282 | 1.2% | 9.1% | 0.6 | 633 339 160 | 11.9% | 10.2% | 0.7 | -5.9% |
| SALVISAR | 475 049 | 8.5% | 1.4% | 0.1 | 197 481 927 | 37.1% | 1.3% | 0.2 | -2.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 407 418 | 23.3% | 11.9% | 2.9 | 825 992 702 | 32.9% | 9.2% | 1.7 | -7.0% |
| BRAINMAX | 74 043 | 75.7% | 100.0% | 0 | 259 390 120 | 81.2% | 100.0% | 0 | 75.7% |
| GOLDLINE PLUS | 830 351 | -3.6% | 45.3% | 0.5 | 2 614 694 229 | -0.9% | 37.3% | -2.6 | -4.6% |
| MIGRENIUM | 578 626 | -12.8% | 0.5% | -0.1 | 176 741 217 | 43.5% | 0.6% | 0.1 | 8.0% |
| MODELAX-N | 1 437 849 | 29.9% | 21.4% | 3.2 | 624 362 657 | 74.8% | 13.7% | 3.5 | 10.5% |
| REDUXIN CAPS | 597 861 | -6.1% | 32.6% | -0.5 | 3 157 734 889 | 13.2% | 45.0% | 2.9 | -4.6% |
| REDUXIN FORTE | 167 730 | 2.8% | 9.1% | 0.7 | 721 073 641 | 14.0% | 10.3% | 0.7 | -4.6% |
| SALVISAR | 535 468 | -0.2% | 1.4% | 0 | 217 218 555 | 21.9% | 1.2% | 0.1 | -0.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 10 524 | 4.9% | 13.1% | 0.1 | 17 889 918 | 2.6% | 8.6% | 0 | 3.8% |
| BRAINMAX | 2 859 | 3.6% | 100.0% | 0 | 9 374 206 | -2.6% | 100.0% | 0 | 3.6% |
| GOLDLINE PLUS | 15 238 | 7.7% | 47.7% | 1.4 | 47 857 867 | 6.7% | 39.3% | 0.8 | 4.6% |
| MIGRENIUM | 10 256 | 7.7% | 0.5% | 0 | 3 503 167 | 6.6% | 0.6% | 0 | -1.1% |
| MODELAX-N | 28 451 | 1.8% | 20.6% | -0.1 | 14 080 012 | 2.7% | 13.8% | -0.1 | 2.0% |
| REDUXIN CAPS | 10 110 | 3.1% | 31.6% | -0.5 | 53 365 882 | 4.9% | 43.8% | 0.1 | 4.6% |
| REDUXIN FORTE | 3 074 | -1.0% | 9.6% | -0.5 | 12 644 430 | -2.4% | 10.4% | -0.7 | 4.6% |
| SALVISAR | 16 399 | 8.7% | 2.2% | 0.2 | 7 281 600 | 9.7% | 2.0% | 0.2 | 0.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 46 299 | 25.2% | 13.5% | 0.1 | 78 544 747 | 16.9% | 8.8% | -0.4 | 24.4% |
| BRAINMAX | 11 465 | 51.5% | 100.0% | 0 | 38 983 593 | 47.0% | 100.0% | 0 | 51.5% |
| GOLDLINE PLUS | 65 432 | 6.8% | 46.1% | 0.2 | 202 749 324 | 6.6% | 37.8% | 0.1 | 6.4% |
| MIGRENIUM | 40 982 | -0.4% | 0.4% | 0 | 13 954 118 | 0.8% | 0.5% | 0 | 3.5% |
| MODELAX-N | 119 788 | 11.4% | 20.1% | -0.5 | 57 090 549 | 12.1% | 13.2% | -0.3 | 13.9% |
| REDUXIN CAPS | 46 001 | 7.6% | 32.4% | 0.4 | 237 476 007 | 7.9% | 44.3% | 0.6 | 6.4% |
| REDUXIN FORTE | 13 965 | 1.4% | 9.8% | -0.5 | 59 017 541 | 0.1% | 11.0% | -0.7 | 6.4% |
| SALVISAR | 58 452 | 22.5% | 1.7% | 0.2 | 25 561 706 | 25.4% | 1.5% | 0.2 | 8.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs